Does the time‐point of relapse influence outcome in pediatric rhabdomyosarcomas?
Pediatric Blood & Cancer2009Vol. 52(7), pp. 772–776
Citations Over TimeTop 13% of 2009 papers
Adrian Mattke, Emily J Bailey, Andreas Schuck, Tobias M. Dantonello, Ivo Leuschner, Thomas Klingebiel, J. Treuner, Ewa Kościelniak
Abstract
TTR has significant influence on prognosis in relapsed RMS. It influences SUR independent of other features such as type of relapse, histology, tumor site, primary treatment time or irradiation in primary treatment.
Related Papers
- → Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma(2012)31 cited
- → Preclinical Testing of Erlotinib in a Transgenic Alveolar Rhabdomyosarcoma Mouse Model(2011)13 cited
- → Clinical Relevance of Molecular Diagnosis in Childhood Rhabdomyosarcoma(2000)37 cited
- → Refractory alveolar rhabdomyosarcoma in an 11-year-old male(2021)3 cited
- → Alveolar Sinonasal Rhabdomyosarcoma in Adults: A Case Report(2013)